Summary: Results from hundreds of genome-wide association studies (GWAS) are now freely available and offer a catalogue of the association between phenotypes across medicine with variants in the genome. With the aim of using this data to better understand therapeutic mechanisms, we have developed Drug Targetor, a web interface that allows the generation and exploration of drug-target networks of hundreds of phenotypes using GWAS data. Drug Targetor networks consist of drug and target nodes ordered by genetic association and connected by drug-target or drug-gene relationship. We show that Drug Targetor can help prioritize drugs, targets and drug-target interactions for a specific phenotype based on genetic evidence.Availability and implement...
Identifying potential and druggable targets for developing new drugs is the first major step for cur...
Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioa...
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...
Genome wide association studies (GWAS) have revealed a large number of links between genome variatio...
Target identification (determining the correct drug targets for a disease) and target validation (de...
Phenome-wide association studies (PheWAS) have been proposed as a possible aid in drug development t...
The use of genetic data can be of great benefit in drug development. When analysed with appropriate ...
Background: Human genome sequencing has enabled the association of phenotypes with genetic loci, but...
Background Attrition is a major issue in drug development with less than 5% of drug development p...
SUMMARY: PhenoScanner is a curated database of publicly available results from large-scale genetic a...
Background: Human genome sequencing has enabled the association of phenotypes with genetic loci, but...
Genome-wide association studies (GWASs) of medication use may contribute to understanding of disease...
Early genome-wide association studies (GWAS) using relatively small samples have identified both rar...
The major depressive disorder (MDD) working group of the Psychiatric Genomics Consortium (PGC) has p...
ObjectiveAs genotyping technology has progressed, genome-wide association studies (GWAS) have mature...
Identifying potential and druggable targets for developing new drugs is the first major step for cur...
Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioa...
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...
Genome wide association studies (GWAS) have revealed a large number of links between genome variatio...
Target identification (determining the correct drug targets for a disease) and target validation (de...
Phenome-wide association studies (PheWAS) have been proposed as a possible aid in drug development t...
The use of genetic data can be of great benefit in drug development. When analysed with appropriate ...
Background: Human genome sequencing has enabled the association of phenotypes with genetic loci, but...
Background Attrition is a major issue in drug development with less than 5% of drug development p...
SUMMARY: PhenoScanner is a curated database of publicly available results from large-scale genetic a...
Background: Human genome sequencing has enabled the association of phenotypes with genetic loci, but...
Genome-wide association studies (GWASs) of medication use may contribute to understanding of disease...
Early genome-wide association studies (GWAS) using relatively small samples have identified both rar...
The major depressive disorder (MDD) working group of the Psychiatric Genomics Consortium (PGC) has p...
ObjectiveAs genotyping technology has progressed, genome-wide association studies (GWAS) have mature...
Identifying potential and druggable targets for developing new drugs is the first major step for cur...
Drug Target Commons (DTC) is a web platform (database with user interface) for community-driven bioa...
BACKGROUND: Drug repositioning offers the possibility of faster development times and reduced risks ...